( June 3, 2026, 02:25 GMT | Official Statement) -- MLex Summary: The proposal by CVS Vets (Australia), part of CVS Group Plc, to acquire 60 percent of the shares in Newman Vet, trading as Paws at Prospect Vet and Eyes at Prospect Vet, is facing a regulatory review in Australia. In a statement on Wednesday, the Australian Competition & Consumer Commission said CVS Group and Paws both supply small animal veterinary services in Adelaide in South Australia. The regulator added that the existing owners of Paws will retain the remaining 40 percent of shares. The regulator is seeking views on the deal until June 10.Statement follows. Questionnaire is attached....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.